Let’s face it, the world is in a state of serious peril. If we don’t get solutions to the already existing problems as soon as possible, we might actually face more danger in the future.
The coronavirus outbreak took the lives of at least 2,200 people ever since it was first reported. However, a Texas-based company is now making the claim that they created a vaccine to fight this deadly virus. Greffex Inc., a company that has a corporate headquarters in Houston has their Scientists hands-on to find the vaccine.
The New York Post reports that the Scientists have completed the vaccine this past week, according to the company’s president and CEO John Price. The vaccine will move to testing on animals by the FDA here in the U.S. and along with similar government agencies, not only China but as well as any other heavily affected countries.
Greffex did not use a virus that has been living or killed to form the vaccine for necessary safety reasons, as Price said. Instead, the company used adenovirus-based vector vaccines, which are widely used against various infectious diseases or cancers.
Price told Houston news outlet KHOU 11, “The trick in making a vaccine is can you scale the vaccine that you’ve made to be able to make a certain number of doses, can you test that vaccine quickly and efficiently and then can you get it into patients.”
“And that’s where we have an edge as well on the other companies that are out there.” An $18.9 million contract that Greffex received in September 2019 produced the vaccine that came from the National Institute of Health’s National Institute for Allergy and Infectious Diseases. According to the Houston Business Journal report, the contract is aimed at exterminating infectious threats.
Government approval is needed to proceed, once the vaccine wins it, Greffex said that he will give it away for free to the hardest-hit countries as Price says. Worldwide, more than 75,700 people have been infected with the coronavirus and all but 11 of the fatalities have occurred in mainland China.